The Hatch-Waxman Act provides a six-month market exclusivity period for the first generic drug applicant to receive FDA approval.

“if you are first to file your application and you get approved you will get six months of exclusivity on the market without any generic competitors and what that meant for generic makers is they could price their drug at about 80% of the brand-name drug price”